Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 6, 2026

Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors
08:11

Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors

Published on: May 19, 2010

Non-stem cell origin for oligodendroglioma.

Anders I Persson1, Claudia Petritsch, Fredrik J Swartling

  • 1Department of Neurology, University of California, San Francisco, 94158, USA.

Cancer Cell
|December 16, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amivantamab induces immune-mediated cytotoxicity in mesothelioma via EGFR and MET engagement.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

A RaPID Macrocyclic Peptide Inhibitor of ROR1/2 Strongly Reduces Proliferation of Diffuse Intrinsic Pontine Glioma Cells.

ACS chemical biology·2026
Same author

Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunity.

Cancer cell·2026
Same author

A tumor-associated photoreceptor signature unifies distinct central nervous system malignancies.

Cancer cell·2026
Same author

Childhood brain tumors instruct cranial hematopoiesis and immunotolerance.

Nature genetics·2026
Same author

Distinct tumor immune microenvironmental landscapes drive divergent immunotherapy responses in glioblastoma.

Neuro-oncology·2026
Same journal

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026
Same journal

Intratumoral B cells under stress.

Cancer cell·2026
Same journal

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Cancer cell·2026
Same journal

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts.

Cancer cell·2026
Same journal

OpenIO: An open framework for AI-native immunotherapy.

Cancer cell·2026
Same journal

From prediction to interpretation in computational pathology.

Cancer cell·2026
See all related articles

Oligodendroglioma brain tumors originate from oligodendrocyte progenitor cells (OPCs), not neural stem cells (NSCs). This progenitor cell origin explains their greater sensitivity to therapy compared to astrocytomas.

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Developmental Neuroscience

Background:

  • Malignant astrocytic brain tumors are highly lethal, with therapy-resistant neural stem cell (NSC)-like cells contributing to poor outcomes.
  • Malignant oligodendroglial brain tumors exhibit greater therapy sensitivity.
  • Understanding the cellular origin of brain tumors is crucial for predicting prognosis and treatment response.

Purpose of the Study:

  • To investigate the cellular origin of oligodendroglioma and its relationship to therapy sensitivity.
  • To determine whether oligodendroglioma cells resemble oligodendrocyte progenitor cells (OPCs) or NSCs.
  • To correlate tumor cell origin with patient prognosis.

Main Methods:

  • Magnetic resonance imaging (MRI) was used to analyze tumor characteristics in murine and human oligodendroglioma.

More Related Videos

Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain
14:26

Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain

Published on: December 20, 2012

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery
07:43

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery

Published on: August 23, 2016

Related Experiment Videos

Last Updated: Jun 6, 2026

Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors
08:11

Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors

Published on: May 19, 2010

Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain
14:26

Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain

Published on: December 20, 2012

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery
07:43

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery

Published on: August 23, 2016

  • Detailed developmental analyses were performed to assess cell markers.
  • Comparison of NSC and OPC markers was conducted to identify enrichment in tumor formation.

    • Main Results:

    • Murine oligodendroglioma cells displayed characteristics of OPCs and were therapy sensitive.
    • OPC markers, rather than NSC markers, were enriched in oligodendroglioma formation.
    • Human oligodendroglioma MRI suggested a white matter (WM) origin, with OPC markers enriching tumor formation.

    Conclusions:

    • Oligodendroglioma cells exhibit hallmarks of OPCs.
    • A progenitor cell origin, specifically OPCs, underlies the improved prognosis observed in oligodendroglioma patients.
    • Distinguishing between NSC and OPC origins may be key to understanding differential brain tumor aggressiveness and therapy response.